Nanoviricides (NNVC) Return on Equity [ROE] (2011 - 2026)
Nanoviricides' Return on Equity [ROE] came in at -93.14% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 24.19 percentage points from -117.33% a year earlier but down 12.29 percentage points from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Nanoviricides' Return on Equity [ROE] was -102.54%, down 1.48 percentage points from FY2025.
- Return on Equity [ROE] has declined in each of the last four fiscal years, with a five-year change of -68.40 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Equity [ROE] was -101.06% in FY2025 (-36.00 pp), -65.07% in FY2024 (-17.93 pp), -47.14% in FY2023 (-16.54 pp) and -30.60% in FY2022 (+3.55 pp).
- The five-year range for quarterly Return on Equity [ROE] is -117.33% (fiscal Q4 2025) to -31.34% (fiscal Q1 2022).
- Year-over-year, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of -9.56 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in fiscal Q4 2026 (a gain of 24.19 percentage points), and the weakest in fiscal Q3 2024 (a drop of 48.73 percentage points).
- Business Quant data shows NNVC's Return on Equity [ROE] at -80.85% (Q3 2026), -92.01% (Q2 2026) and -111.90% (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.45 Bn | 1,141.04 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 637.59 Bn | 556.11 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 504.05 Bn | 477.16 Bn | 12.70 Bn | - |
| 4 | Merck | 377.18 Bn | 331.56 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 304.13 Bn | 268.12 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.62 Bn | 241.31 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.83 Bn | 197.23 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.07 Bn | 168.27 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.51 Bn | 119.15 Bn | 10.94 Bn | 4.97% |
| 10 | Nanoviricides | 29.58 Mn | 17.24 Mn | - | -93.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -93.14% |
| Mar 31, 2026 | -80.85% |
| Dec 31, 2025 | -92.01% |
| Sep 30, 2025 | -111.90% |
| Jun 30, 2025 | -117.33% |
| Mar 31, 2025 | -102.68% |
| Dec 31, 2024 | -92.97% |
| Sep 30, 2024 | -89.61% |
| Jun 30, 2024 | -76.57% |
| Mar 31, 2024 | -84.42% |
| Dec 31, 2023 | -75.11% |
| Sep 30, 2023 | -65.34% |
| Jun 30, 2023 | -52.55% |
| Mar 31, 2023 | -35.69% |
| Dec 31, 2022 | -33.25% |
| Sep 30, 2022 | -31.65% |
| Jun 30, 2022 | -33.89% |
| Mar 31, 2022 | -32.80% |
| Dec 31, 2021 | -31.82% |
| Sep 30, 2021 | -31.34% |
API Access
Nanoviricides Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();